Development of fluticasone propionate and comparison with other inhaled corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 4 SUPPL., 1998, Pages

  Johnson, Malcolm ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; Fluticasone propionate; Inhaled corticosteroids; Structure activity relationships

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETHASONE 17 MONOPROPIONATE; BUDESONIDE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; FLUNISOLIDE; FLUOCINOLONE ACETONIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR; HISTAMINE; HLA DR ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; MOMETASONE FUROATE; T LYMPHOCYTE ANTIGEN; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CONFERENCE PAPER; DENDRITIC CELL; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LIPOPHILICITY; PHARMACODYNAMICS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; HUMANS; LUNG; RECEPTORS, GLUCOCORTICOID; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031957726     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70155-1     Document Type: Article

References (29)

1. Barnes PJ, Adcock IM. Anti-inflammatory actions of steroids: molecular mechanism. Trends Pharmacol Sci 1993;14:436-41.
2. Phillipps GH. Locally active corticosteroids: structure-activity relationships. In: Wilson L, Markes R, editor. Mechanisms of topical corticosteroid activity. London: Churchill Livingstone; 1976. p. 1-18.
3. Phillipps GH, Bailey EJ, Bain BM, Borella RA, Buckton JB, Clark JC, et al. Synthesis and structure-activity relationships in a series of anti-inflammatory corticosteroid analogues, halomethyl androstane-17β-carbothiates and 17β-carboselenoates. J Med Chem 1994;37:3717-29.
4. Tonelli G, Thibault L, Ringler I. A bio-assay for the concomitant assessment of the antiphlogistic and thymolytic activities of topically applied corticoids. Endocrinology 1965;77:625-34.
5. Zenker N, Bernstein DE. The estimation of small amounts of corticosterone in rat plasma. J Biol Chem 1958;231:695-701.
6. McKenzie AW. Percutaneous absorption of steroids. Arch Dermatol 1962;86:611-4.
7. Weeks CM, Duax WL, Wolff ME. A comparison of the molecular structures of six corticosteroids. J Am Chem Soc 1973;95:2865-8.
8. Phillipps GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990;84(suppl):19-23.
9. Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996;97:169-76.
10. Högger P, Rawert L, Rohdewald P. Dissolution tissue binding and kinetics of receptor binding of inhaled glucocorticoids. Eur Respir J 1993;6:584s.
11. Högger P, Bonsmann U, Rohdewald P. Efflux of glucocorticoids from human lung tissue to human plasma in vitro. Eur Respir J 1994;7:382s.
12. Högger P, Esmailpour N, Rabe K, Heitmann U, Nakashima N, Rhodewald P. Distribution of inhaled fluticasone propionate between lung tissue and blood plasma in vivo. Eur Respir J 1995;8:303S.
13. Van den Bosch JMM, Westermann CJJ, Aumann J, Edsbacker S, Tönneffon M, Selrous O. Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos 1993;14:455-9.
14. Högger P, Rohdewald P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994;59:597-602.
15. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84(suppl):25-9.
16. Adcock IM, Barnes PJ. Ligand-induced differentiation of glucocorticoid receptor transrepression and transactivation. In: Acute and chronic inflammation in the respiratory tract, International Respiratory Forum. Reading UK: Colwood Publications; 1996. p. 25.
17. Cruikshank W, Masterson J, Center D. Effects of fluticasone propionate on random and stimulated T cell migration. In: Acute and chronic inflammation in the respiratory tract, International Respiratory Forum. Reading UK: Colwood Publications; 1996. p. 19.
18. English AF, Neate MS, Quint DJ, Sareen M. Biological activities of some corticosteroids used in asthma. Am J Respir Crit Care Med 1994;149:A212.
19. Umland SP, Nahrebne MS, Razac S, Billah MM, Egan RW. Effects of mometasone furoate and other glucocorticoids on cytokine production from cultured peripheral blood CD4+ T cells. J Allergy Clin Immunol 1996;97:423.
20. Bickel CA, Stellato C, Schleimer RP. Comparison of the effect of inhaled glucocorticoids on human basophil histamine release and eosinophil viability. J Allergy Clin Immunol 1997;99:1632.
21. Kita H, Hagen JB, Gleich GJ. Fluticasone propionate is the most potent glucocorticoid in the induction of apoptosis of eosinophils. In: Acute and chronic inflammation in the respiratory tract, International Respiratory Forum. Reading UK: Colwood Publications; 1996. p. 17.
22. Johnson M. Anti-inflammatory properties of fluticasone propionate. Int Arch Allergy Immunol 1995;107:439-40.
23. Adler KB, Krunkosky TA, Fischer BM. Effects of tumour necrosis factor-alpha on airway epithelial cells in vitro. In: Acute and chronic inflammation in the respiratory tract, International Respiratory Forum. Reading UK: Colwood Publications; 1996. p. 18.
24. Abbinante-Nissen JM, Simpson LG, Leikauf GD. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Respir Crit Care Med 1994;149:A869.
25. Dahlberg E, Thalén A, Brattsand R, Gustafsson JA, Johansson U, Römpke K. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16α, 17α-acetyl-substituted glucocorticoids. Mol Pharmacol 1983;25:70-8.
26. Booth H, Gardiner PV, Ward C, Walls A, Hendrick DJ, Walters EH. Effect of fluticasone on airway inflammation as assessed by bronchoalveolar lavage (BAL). Eur Respir J 1993;6(suppl 17):584S.
27. Möller GM, Overbeek SE, van Helden-Meeuwsen CG, de Jong TAW, Mulder PG, Drexloge HA, et al. Glucocorticoid therapy is associated with modulation of dendritic cells in bronchial mucosa of atopic asthmatic subjects. In: Acute and chronic inflammation in the respiratory tract, International Respiratory Forum. Reading UK: Colwood Publications; 1996. p. 16.
28. Warner JA, Shute JK, Howarth PH. Effect of therapy on matrix metallo-proteinase (MMP) activity in the broncho-alveolar lavage (BAL) of patients with mild asthma. Am J Resp Crit Care Med In press.
29. Derendorf H, Hochhaus G, Möllermann H, Barth J, Krieg M, Jurn S, et al. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol 1993;33:115-23.